TLR2 and neoplasm: Notably, HSP72 on the surfaces of tumor-derived exosomes (TDEs) can produce IL-6 to trigger Stat3 activation in MDSCs in a TLR2/MyD88-dependent manner, which subsequently inhibits T-cell differentiation.